Video

Advances in HER2 negative breast cancers- Diagnosis & Management

Debate : Every HR+ve MBC should receive CDK 4/6 inhibitors Yes/no?

Chairpersons :

Dr. A K Malhotra, Dr. Shekhar Patil

Speaker :

Dr. Amol Dongre vs Dr. Sandeep Batra

Moderator :

Dr. D C Doval